Gepostet in 2018.12.18. 20:14
NEW YORK, Dec. 18, 2018 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Nobilis Health Corporation (“Nobilis” or the “Company”) (NYSEAMERICAN: HLTH). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 9980. The investigation concerns whether Nobilis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On August 2, 2018, Nobilis reported reduced revenue for the second quarter of 2018, citing a $2.4 million adjustment to its accounts receivable. On this news, Nobilis’s stock price fell $0.20 per share, more than 17%, to close at $0.95 per share ...
Gepostet in der Kategorie Wirtschaft (Anzahl der ansichten:) 8